Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
13.09
+0.70 (5.65%)
Jul 23, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Microbiome Therapeutics
126.33M
Log In
Log In
Log In
Log In
Upgrade
Microbiome Therapeutics Growth
1672.24%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
126.33M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1672.24%
Log In
Log In
Log In
Log In
Upgrade